Caligan Partners Amends Standard BioTools Stake, Signals Continued Activism
Ticker: LAB · Form: SC 13D/A · Filed: Jan 8, 2024 · CIK: 1162194
| Field | Detail |
|---|---|
| Company | Standard Biotools Inc. (LAB) |
| Form Type | SC 13D/A |
| Filed Date | Jan 8, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: activist-investing, insider-ownership, amendment
TL;DR
**Caligan Partners is still actively involved with Standard BioTools, expect potential strategic shifts.**
AI Summary
Caligan Partners LP, an activist investor, filed an Amendment No. 7 to its Schedule 13D on January 5, 2024, regarding its ownership in Standard BioTools Inc. This filing updates previous disclosures, indicating a continued active interest in the company by Caligan Partners. For investors, this matters because activist investors like Caligan often push for strategic changes, which can lead to significant stock price movements, either positive or negative, depending on the nature and success of their initiatives.
Why It Matters
Activist investor involvement often signals potential for corporate changes, which can impact stock valuation and future performance for Standard BioTools shareholders.
Risk Assessment
Risk Level: medium — Activist investor involvement can introduce volatility and uncertainty, as their demands may or may not align with all shareholders' interests or company strategy.
Analyst Insight
Investors should monitor future filings from Caligan Partners LP and news related to Standard BioTools Inc. for any announced strategic initiatives or changes in board composition, as these could significantly influence the stock's direction.
Key Players & Entities
- Caligan Partners LP (company) — the filing person and an activist investor
- Standard BioTools Inc. (company) — the subject company in which Caligan Partners holds shares
- David Johnson (person) — contact person for Caligan Partners LP
- Eleazer Klein, Esq. (person) — legal counsel from Schulte Roth & Zabel LLP for Caligan Partners
- Adriana Schwartz, Esq. (person) — legal counsel from Schulte Roth & Zabel LLP for Caligan Partners
- $0.001 (dollar_amount) — par value per share of Standard BioTools Common Stock
Forward-Looking Statements
- Caligan Partners LP will continue to engage with Standard BioTools Inc. management or board to advocate for strategic changes. (Caligan Partners LP) — medium confidence, target: Q2 2024
FAQ
What is the purpose of this specific filing, SC 13D/A Amendment No. 7?
This filing is an amendment (Amendment No. 7) to a previously filed Schedule 13D, indicating that Caligan Partners LP is updating information regarding its beneficial ownership and intentions concerning Standard BioTools Inc. as of January 5, 2024.
Who is the reporting person in this SC 13D/A filing?
The reporting person is Caligan Partners LP, located at 515 Madison Avenue, 8th Floor, New York, NY 10022.
What is the CUSIP number for Standard BioTools Inc.'s securities mentioned in the filing?
The CUSIP number for Standard BioTools Inc.'s Common Stock, par value $0.001 per share, is 34385P108.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was January 5, 2024.
Who are the legal contacts for Caligan Partners LP regarding this filing?
The legal contacts authorized to receive notices and communications for Caligan Partners LP are Eleazer Klein, Esq. and Adriana Schwartz, Esq. of Schulte Roth & Zabel LLP.
Filing Stats: 1,190 words · 5 min read · ~4 pages · Grade level 12.9 · Accepted 2024-01-08 17:00:14
Key Financial Figures
- $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie
Filing Documents
- p24-0050sc13da.htm (SC 13D/A) — 48KB
- 0000902664-24-000080.txt ( ) — 50KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: January 8, 2024 CALIGAN PARTNERS LP By: /s/ David Johnson Name: David Johnson Title: Partner /s/ David Johnson DAVID JOHNSON CUSIP No. 34385P108 SCHEDULE 13D/A Page 6 of 6 Pages ANNEX A Transactions in the Shares of Common Stock of the Issuer During the Past Sixty (60) Days The following table sets forth all transactions in the shares of Common Stock reported herein effected in the past sixty (60) days. Except as noted below, all such transactions were effected by the Reporting Persons in the open market through brokers and the price per share excludes commissions. Trade Date Shares Purchased (Sold) Price Per Share ($) 11/21/2023 (230,000) 2.32 11/22/2023 (350,000) 2.35